NTRK Somatic Fusions and Tumor Agnostic Treatment in Pediatric Cancers
Neurotrophic tyrosine receptor kinase (NTRK) gene rearrangements have been recently identified and developed as one of the biomarkers that have been utilized as new targets for cancer therapy. NTRK gene fusions have taken their place in individualized targeted therapy by being used as a predictive (...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Rabia Yılmaz
2022-11-01
|
Series: | Journal of Contemporary Medicine |
Subjects: | |
Online Access: | https://dergipark.org.tr/tr/download/article-file/2414338 |